NE 1640
Latest Information Update: 18 Jul 1995
At a glance
- Originator Neose Technologies
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 18 Jul 1995 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)
- 24 Feb 1995 Preclinical development for Bacterial infections in USA (Unknown route)